BIT Group opens new R&D Center of Excellence in the US

BIT Group has announced the opening of its new 22,500 sq. ft. "Center of Excellence for Life Science and IVD Products" for BIT USA. A world leader in contract development of IVD products, BIT Group operates two distinct BIT USA facilities - one that is focused on R&D and the other which is dedicated to instrument manufacturing and after sale services. The new Center of Excellence is located close to the Santa Ana Airport in the heart of the Irvine Spectrum district, while the manufacturing facility is less than an hour away in nearby San Diego.

The BIT USA R&D Center of Excellence boasts innovative capabilities for developing instrument prototypes; advanced 3D printing capabilities for rapid prototyping; and a dedicated CNC machine shop. Additionally, the new facility houses a wet lab - where instruments can be operated using customers' reagents and samples, an EMC-shielded test room, optical and electronic lab.

"Our new R&D Center of Excellence reflects the growing demand of our clients for comprehensive, advanced R&D services and helps us to sustain our leading market position by consolidating all R&D know-how," said BIT Group CEO, Marius Balger. "We have constructed this Center to stimulate superior Team Collaboration and multi-disciplinary interactions. Additionally, the facility supports high-level R&D collaboration with our clients, with restricted areas providing a safe and confidential environment."

Source:

BIT Group 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Canada’s proactive policies reduce drug shortages far more effectively than the U.S.